Comments
Loading...

Perspective Therapeutics

CATXAMEX
Logo brought to you by Benzinga Data
$3.25
0.113.50%
At close: -
Consensus Rating1
Buy
Highest Price Target1
$21.00
Lowest Price Target1
$1.40
Consensus Price Target1
$11.59

Perspective Therapeutics (AMEX:CATX) Stock, Analyst Ratings, Price Targets, Forecasts

Perspective Therapeutics Inc has a consensus price target of $11.59 based on the ratings of 10 analysts. The high is $21 issued by Truist Securities on September 25, 2024. The low is $1.4 issued by JonesTrading on November 15, 2023. The 3 most-recent analyst ratings were released by RBC Capital, B of A Securities, and Oppenheimer on November 25, 2024, November 25, 2024, and November 22, 2024, respectively. With an average price target of $12.67 between RBC Capital, B of A Securities, and Oppenheimer, there's an implied 286.36% upside for Perspective Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jul
2
Aug
5
Sep
4
Oct
2
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
B of A Securities
Oppenheimer
Wedbush
UBS

1calculated from analyst ratings

Analyst Ratings for Perspective Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Perspective Therapeutics (CATX) stock?

A

The latest price target for Perspective Therapeutics (AMEX:CATX) was reported by RBC Capital on November 25, 2024. The analyst firm set a price target for $16.00 expecting CATX to rise to within 12 months (a possible 392.31% upside). 27 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Perspective Therapeutics (CATX)?

A

The latest analyst rating for Perspective Therapeutics (AMEX:CATX) was provided by RBC Capital, and Perspective Therapeutics maintained their outperform rating.

Q

When was the last upgrade for Perspective Therapeutics (CATX)?

A

There is no last upgrade for Perspective Therapeutics

Q

When was the last downgrade for Perspective Therapeutics (CATX)?

A

The last downgrade for Perspective Therapeutics Inc happened on November 25, 2024 when B of A Securities changed their price target from $24 to $6 for Perspective Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Perspective Therapeutics (CATX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Perspective Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Perspective Therapeutics was filed on November 25, 2024 so you should expect the next rating to be made available sometime around November 25, 2025.

Q

Is the Analyst Rating Perspective Therapeutics (CATX) correct?

A

While ratings are subjective and will change, the latest Perspective Therapeutics (CATX) rating was a maintained with a price target of $25.00 to $16.00. The current price Perspective Therapeutics (CATX) is trading at is $3.25, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch